Skip to main content
Clinical Trials/EUCTR2004-003255-39-FI
EUCTR2004-003255-39-FI
Active, not recruiting
Not Applicable

Treatment protocol for elderly patients with mantle cell lymphoma (MCL). A phase II study of the Finnish Lymphoma Group.

The Finnish Lymphoma group0 sites30 target enrollmentDecember 1, 2004

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Mantle cell lymphoma
Sponsor
The Finnish Lymphoma group
Enrollment
30
Status
Active, not recruiting
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2004
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
The Finnish Lymphoma group

Eligibility Criteria

Inclusion Criteria

  • Inclusion criteria
  • \-Patients with histologically confirmed mantle cell lymphoma
  • \-Advanced stage II\-IV
  • \-Previously untreated
  • \-65 years and older, or 55\-65 years if not eligible for high dose chemotherapy
  • \-Written informed consent
  • \-Adequate organ function
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1\.2 Adults (18\-64 years)

Exclusion Criteria

  • Exclusion criteria
  • \-Severe somatic or psychiatric disease including cardiac, pulmonary, renal and CNS diseases, severe chronic infections, and active malignant diseases
  • \-Poor compliance

Outcomes

Primary Outcomes

Not specified

Similar Trials